These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 25828731)

  • 1. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay.
    Noumsi GT; Billingsley KL; Moulds JM
    Transfus Med; 2015 Apr; 25(2):92-100. PubMed ID: 25828731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Monocyte Monolayer Assay: Past, Present and Future.
    Tong TN; Cen S; Branch DR
    Transfus Med Rev; 2019 Jan; 33(1):24-28. PubMed ID: 30139679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-AnWj causing acute hemolytic transfusion reactions in a patient with aplastic anemia.
    Xu Z; Duffett L; Tokessy M; Cote J; Goldman M; Saidenberg E
    Transfusion; 2012 Jul; 52(7):1476-81. PubMed ID: 22233405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte monolayer assay in pre-transfusion testing: A magic key in transfusing patients with recurrent bad cross-match due to alloimmunization.
    El-Sayed HAN; Abdollah MRA; Raafat SN; Ragab D
    J Immunol Methods; 2021 May; 492():112968. PubMed ID: 33465386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies.
    Arndt PA; Garratty G
    Transfusion; 2004 Sep; 44(9):1273-81. PubMed ID: 15318848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cell transfusion in patients with anti-Yt
    Wong SM; Cawthorne T; Dennington PM; Hong FS
    Transfusion; 2021 Feb; 61(2):379-384. PubMed ID: 33410173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India.
    Thakral B; Saluja K; Sharma RR; Marwaha N
    Hematology; 2008 Oct; 13(5):313-8. PubMed ID: 18854096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion of multiple units of Js(b+) red blood cells in the presence of anti-Jsb in a patient with sickle beta-thalassemia disease and a review of the literature.
    Yuan S; Ewing NP; Bailey D; Salvador M; Wang S
    Immunohematology; 2007; 23(2):75-80. PubMed ID: 18004938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
    Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
    Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of transfusion of K:11 erythrocytes in a patient with anti-K11 antibody.
    Kelley CM; Karwal MW; Schlueter AJ; Olson JD
    Vox Sang; 1998; 74(3):205-8. PubMed ID: 9595651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohematologic study and transfusion approach to patients with public antibodies].
    Solves P; de la Rubia J; Arriaga F; Cervera J; Arnao M; Carpio N; Marty ML
    Sangre (Barc); 1997 Feb; 42(1):25-9. PubMed ID: 9229799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management.
    Shirey RS; Boyd JS; Parwani AV; Tanz WS; Ness PM; King KE
    Transfusion; 2002 Nov; 42(11):1435-41. PubMed ID: 12421216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and laboratorial determinants of the clinical relevance of antibodies of undetermined specificity.
    de Albuquerque da Veiga Conrado MC; Cardoso RA; Dezan MR; Oliveira VB; Neto ADC; Ziza KC; Krieger JE; Pereira AC; Sabino EC; Rocha V; Mendrone-Júnior A; Dinardo CL
    Vox Sang; 2019 Aug; 114(6):616-621. PubMed ID: 31183870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the clinical significance of blood group alloantibodies that are causing problems in pretransfusion testing.
    Garratty G
    Vox Sang; 1998; 74 Suppl 2():285-90. PubMed ID: 9704458
    [No Abstract]   [Full Text] [Related]  

  • 15. Red-blood-cell alloimmunisation in relation to antigens' exposure and their immunogenicity: a cohort study.
    Evers D; Middelburg RA; de Haas M; Zalpuri S; de Vooght KM; van de Kerkhof D; Visser O; Péquériaux NC; Hudig F; Schonewille H; Zwaginga JJ; van der Bom JG
    Lancet Haematol; 2016 Jun; 3(6):e284-92. PubMed ID: 27264038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed hemolytic transfusion reaction due to anti-Go(a), an antibody against the low-prevalence Gonzales antigen.
    Larson PJ; Lukas MB; Friedman DF; Manno CS
    Am J Hematol; 1996 Dec; 53(4):248-50. PubMed ID: 8948664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red cell alloantibodies in patients with haemoglobinopathies.
    Hmida S; Mojaat N; Maamar M; Bejaoui M; Mediouni M; Boukef K
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):363-6. PubMed ID: 7892131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The monocyte monolayer assay, an
    Nance SJT
    Immunohematology; 2023 Jun; 39(2):61-69. PubMed ID: 37405851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transfusion management of patients with red blood cell antibodies].
    Bujandrić NB; Grujić JN; Krga-Milanović MM
    Med Pregl; 2013; 66(11-12):491-6. PubMed ID: 24575638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chemiluminescence test for predicting the outcome of transfusing incompatible blood.
    Hadley A; Wilkes A; Poole J; Arndt P; Garratty G
    Transfus Med; 1999 Dec; 9(4):337-42. PubMed ID: 10583888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.